Recently, aberrant NLRP3 inflammasome activation has been shown to be related to the progress of several human diseases, including gout, type 2 diabetes (T2D), atherosclerosis and influenza virus- (IV)-induced inflammation (18, 19). The gene discussed is NLRP3; the disease is gout.